Explore approved biosimilar medicines
| # | Medicine | Status | Active Substance | Therapeutic Area | Developer | Published Date |
|---|---|---|---|---|---|---|
| 11 | Vislyfa | Opinion | ranibizumab | Wet Macular Degeneration;Macular Edema;Diabetes Complications;Retinal Vein Occlusion;Choroidal Neovascularization | Lupin Europe GmbH | 22-05-2026 |
| 12 | Dazparda | Authorised | insulin aspart | Diabetes Mellitus | Gan & Lee Pharmaceuticals Europe GmbH | 27-02-2026 |
| 13 | Tuyory | Authorised | tocilizumab | Arthritis, Rheumatoid;Arthritis, Juvenile;Cytokine Release Syndrome;Giant Cell Arteritis;COVID-19 virus infection | Chemical Works of Gedeon Richter Plc. (Gedeon Richter Plc.) | 27-02-2026 |
| 14 | Zercepac | Authorised | trastuzumab | Breast Neoplasms;Stomach Neoplasms | Accord Healthcare S.L.U. | 28-07-2020 |
| 15 | Usrenty | Authorised | ustekinumab | Crohn Disease | Biosimilar Collaborations Ireland Limited | 25-07-2025 |
| 16 | Xbonzy | Authorised | denosumab | Giant Cell Tumor of Bone;Neoplasms, Bone Tissue | Reddy Holding GmbH | 19-09-2025 |
| 17 | Imuldosa | Authorised | ustekinumab | Crohn Disease;Psoriasis;Arthritis, Psoriatic | Accord Healthcare S.L.U. | 18-10-2024 |
| 18 | Omlyclo | Authorised | omalizumab | Asthma;Urticaria | Celltrion Healthcare Hungary Kft. | 22-03-2024 |
| 19 | Denbrayce | Authorised | denosumab | Neoplasms, Bone Tissue;Giant Cell Tumor of Bone | Mabxience Research SL | 25-04-2025 |
| 20 | Remsima | Authorised | infliximab | Arthritis, Psoriatic;Spondylitis, Ankylosing;Colitis, Ulcerative;Psoriasis;Crohn Disease;Arthritis, Rheumatoid | Celltrion Healthcare Hungary Kft. | 21-06-2018 |
Ready to transform your strategic intelligence? Let's talk
Get latest pharmaceutical insights, blogs, and strategic updates directly in your inbox.